000147127 001__ 147127
000147127 005__ 20241216113259.0
000147127 0247_ $$2doi$$a10.1017/S0007114512001511
000147127 0248_ $$2sideral$$a77350
000147127 037__ $$aART-2012-77350
000147127 041__ $$aeng
000147127 100__ $$0(orcid)0000-0002-7985-9912$$aRodríguez, G.$$uUniversidad de Zaragoza
000147127 245__ $$aEffect of n-3 long chain polyunsaturated fatty acids during the perinatal period on later body composition
000147127 260__ $$c2012
000147127 5060_ $$aAccess copy available to the general public$$fUnrestricted
000147127 5203_ $$aA systematic review to identify studies reporting the effects of n-3 long chain polyunsaturated fatty acids (LCPUFA) intake, during pregnancy and postnatally, on infants and young children's body composition was performed. A structured search strategy was performed in the MEDLINE (PubMed), EMBASE, and LILACS databases. Inclusion and exclusion criteria were defined according to the research question. Only those studies addressing the relationship between n-3 LCPUFA exposure during the perinatal period and later adiposity measured in terms of weight, height, body mass index (BMI), skinfold thickness and/or circumferences were included regardless of the study design. Studies quality was scored and were thereafter categorised into those reporting on maternal intake of n-3 LCPUFA during pregnancy or lactation (6 publications) or on infant's n-3 LCPUFA intake (7 publications). Two studies showed inverse associations between maternal n-3 LCPUFA intake and children's later body composition (lower adiposity, BMI or body weight), two showed direct associations and no effects were observed in the remaining two studies. Among those studies focusing on n-3 LCPUFA intake through enriched infant formulas; three observed no effect on later body composition and two showed higher weight and adiposity with increased amounts of n-3 LCPUFA. Reversely, in two studies weight and fat mass decreased. In conclusion, reported body composition differences in infants and young children were not clearly explained by perinatal n-3 LCPUFA intake via supplemented formulas, breastfeeding or maternal intakes of n-3 LCPUFA during pregnancy and lactation. Associated operational mechanisms including n-3 LCPUFA doses and sources applied are not sufficiently explained and therefore no conclusions could be made.
000147127 536__ $$9info:eu-repo/grantAgreement/ES/Spanish Ministry of Health/RD08-0072
000147127 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc-nd$$uhttp://creativecommons.org/licenses/by-nc-nd/3.0/es/
000147127 590__ $$a3.302$$b2012
000147127 591__ $$aNUTRITION & DIETETICS$$b18 / 75 = 0.24$$c2012$$dQ1$$eT1
000147127 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/acceptedVersion
000147127 700__ $$0(orcid)0000-0002-2219-3646$$aIglesia, I.$$uUniversidad de Zaragoza
000147127 700__ $$aBel-Serrat, S.$$uUniversidad de Zaragoza
000147127 700__ $$0(orcid)0000-0003-0454-653X$$aMoreno, L. A.$$uUniversidad de Zaragoza
000147127 7102_ $$11006$$2255$$aUniversidad de Zaragoza$$bDpto. Fisiatría y Enfermería$$cÁrea Enfermería
000147127 7102_ $$11006$$2X$$aUniversidad de Zaragoza$$bDpto. Fisiatría y Enfermería$$cProy. investigación DZA
000147127 7102_ $$11010$$2670$$aUniversidad de Zaragoza$$bDpto. Pediatría Radiol.Med.Fís$$cÁrea Pediatría
000147127 773__ $$g107, S2 (2012), S117-S128$$pBr. J. Nutr.$$tBritish journal of nutrition$$x0007-1145
000147127 8564_ $$s238699$$uhttps://zaguan.unizar.es/record/147127/files/texto_completo.pdf$$yPostprint
000147127 8564_ $$s1129626$$uhttps://zaguan.unizar.es/record/147127/files/texto_completo.jpg?subformat=icon$$xicon$$yPostprint
000147127 909CO $$ooai:zaguan.unizar.es:147127$$particulos$$pdriver
000147127 951__ $$a2024-12-16-11:31:52
000147127 980__ $$aARTICLE